f74f8ade03d6f160dd75c8ed4a2e7a94  pmc_10848160.pdf
58ad1e103d70726931c5cca03006f7d127a19cdf  pmc_10848160.pdf
dfba1a76b03ee8d4ba185c894270dea9775b9f41e58458d4e9c04234daaad43c  pmc_10848160.pdf

Title:           Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Subject:         
Keywords:        autoimmune disease (AID), immune checkpoint inhibitors (ICI), autoimmune liver diseases (AILD), immune related adverse effects (irAEs), PD-1/PD-L1 immune checkpoint inhibitors, autoimmune hepatitis (AIH), primary sclerosing cholangites (PSC), primary biliary cholangitis (PBC)
Author:          Lorenz Kocheise
CreationDate:    Tue Jan 23 09:57:20 2024 CET
ModDate:         Tue Jan 23 09:57:20 2024 CET
Custom Metadata: no
Metadata Stream: yes
Tagged:          no
UserProperties:  no
Suspects:        no
Form:            none
JavaScript:      no
Pages:           2
Encrypted:       no
Page size:       595.389 x 841.663 pts (A4)
Page rot:        0
File size:       255576 bytes
Optimized:       yes
PDF version:     1.6


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
ONLHBO+AdvTTd3a5f740                 Type 1C           WinAnsi          yes yes no     148  0
ONLHIM+AdvTTd3a5f740+fb              Type 1C           Custom           yes yes yes    149  0
ONLHJN+AdvPSA18C                     Type 1C           WinAnsi          yes yes no     150  0
ONLHJO+AdvTTd3a5f740+20              Type 1C           WinAnsi          yes yes no     158  0
ONLHJP+AdvTT9b12cd41                 Type 1C           WinAnsi          yes yes no     159  0
ONLHKP+AdvPSA323                     Type 1C           WinAnsi          yes yes no     160  0
ONLHLA+AdvTT9b12cd41+20              Type 1C           WinAnsi          yes yes no     161  0
ONLHMB+AdvTT2c8ce45a                 Type 1C           WinAnsi          yes yes no     165  0
ONLJBJ+AdvTT9b12cd41+fb              Type 1C           Custom           yes yes yes    168  0
ONLJBK+AdvTTd168d80a.I               Type 1C           WinAnsi          yes yes no     169  0
ONLJDL+AdvOT1ef757c0+fb              Type 1C           Custom           yes yes yes     24  0
ONLJDM+AdvTT749c1f5a.I               Type 1C           WinAnsi          yes yes no      22  0
ONLJEN+AdvOT7d6df7ab.I               Type 1C           WinAnsi          yes yes no      23  0
ONLJDK+AdvOT1ef757c0                 Type 1C           WinAnsi          yes yes no      25  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2025-02-06 02:51:37 CET
 RepresentationInformation: pmc_10848160.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2025-02-05 02:55:16 CET
  Size: 255576
  Format: PDF
  Version: 1.6
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 210
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseOutlines
    Outlines: 
     Item: 
      Title: Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
      Destination: bmark_1595139173
      Children: 
       Item: 
        Title: Publisher’s note
        Destination: bmark_-1256977648
   Info: 
    Title: Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
    Author: Lorenz Kocheise
    Subject: 
    Keywords: autoimmune disease (AID), immune checkpoint inhibitors (ICI), autoimmune liver diseases (AILD), immune related adverse effects (irAEs), PD-1/PD-L1 immune checkpoint inhibitors, autoimmune hepatitis (AIH), primary sclerosing cholangites (PSC), primary biliary cholangitis (PBC)
    CreationDate: Tue Jan 23 09:57:20 CET 2024
    ModDate: Tue Jan 23 09:57:20 CET 2024
   ID: 0x115b7f915623a711cefbeb95290b0f30, 0xab8e4e6c72b37b44bdbdd267d5d1d767
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2919
      ImageHeight: 577
      BitsPerSample: 8
      BitsPerSampleUnit: integer
   Fonts: 
    Type1: 
     Font: 
      BaseFont: ONLHKP+AdvPSA323
      FontSubset: true
      FirstChar: 136
      LastChar: 180
      FontDescriptor: 
       FontName: ONLHKP+AdvPSA323
       Flags: Nonsymbolic
       FontBBox: -156, -239, 1104, 770
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLHLA+AdvTT9b12cd41+20
      FontSubset: true
      FirstChar: 134
      LastChar: 150
      FontDescriptor: 
       FontName: ONLHLA+AdvTT9b12cd41+20
       Flags: Nonsymbolic
       FontBBox: -114, -166, 1010, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLHMB+AdvTT2c8ce45a
      FontSubset: true
      FirstChar: 40
      LastChar: 121
      FontDescriptor: 
       FontName: ONLHMB+AdvTT2c8ce45a
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 947, 895
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLJBJ+AdvTT9b12cd41+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: ONLJBJ+AdvTT9b12cd41+fb
       Flags: Symbolic
       FontBBox: 0, 0, 854, 697
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ONLJBK+AdvTTd168d80a.I
      FontSubset: true
      FirstChar: 46
      LastChar: 117
      FontDescriptor: 
       FontName: ONLJBK+AdvTTd168d80a.I
       Flags: Serif, Nonsymbolic
       FontBBox: -145, -208, 968, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLHBO+AdvTTd3a5f740
      FontSubset: true
      FirstChar: 35
      LastChar: 252
      FontDescriptor: 
       FontName: ONLHBO+AdvTTd3a5f740
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 916, 885
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLHIM+AdvTTd3a5f740+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: ONLHIM+AdvTTd3a5f740+fb
       Flags: Symbolic
       FontBBox: 0, 0, 906, 708
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ONLHJN+AdvPSA18C
      FontSubset: true
      FirstChar: 136
      LastChar: 180
      FontDescriptor: 
       FontName: ONLHJN+AdvPSA18C
       Flags: Nonsymbolic
       FontBBox: -156, -208, 1125, 802
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLJDM+AdvTT749c1f5a.I
      FontSubset: true
      FirstChar: 37
      LastChar: 116
      FontDescriptor: 
       FontName: ONLJDM+AdvTT749c1f5a.I
       Flags: Serif, Nonsymbolic
       FontBBox: -145, -208, 989, 885
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLJEN+AdvOT7d6df7ab.I
      FontSubset: true
      FirstChar: 40
      LastChar: 117
      FontDescriptor: 
       FontName: ONLJEN+AdvOT7d6df7ab.I
       Flags: Nonsymbolic
       FontBBox: -135, -250, 1000, 854
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLJDL+AdvOT1ef757c0+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: ONLJDL+AdvOT1ef757c0+fb
       Flags: Symbolic
       FontBBox: 0, -10, 781, 708
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ONLJDK+AdvOT1ef757c0
      FontSubset: true
      FirstChar: 35
      LastChar: 122
      FontDescriptor: 
       FontName: ONLJDK+AdvOT1ef757c0
       Flags: Serif, Nonsymbolic
       FontBBox: -20, -250, 947, 854
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLHJO+AdvTTd3a5f740+20
      FontSubset: true
      FirstChar: 134
      LastChar: 150
      FontDescriptor: 
       FontName: ONLHJO+AdvTTd3a5f740+20
       Flags: Nonsymbolic
       FontBBox: -114, -166, 1062, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ONLHJP+AdvTT9b12cd41
      FontSubset: true
      FirstChar: 38
      LastChar: 252
      FontDescriptor: 
       FontName: ONLHJP+AdvTT9b12cd41
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 906, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="3.1-701">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Lorenz Kocheise</rdf:li>
               <rdf:li>Ignazio Piseddu</rdf:li>
               <rdf:li>Joscha Vonderlin</rdf:li>
               <rdf:li>Eric T. Tjwa</rdf:li>
               <rdf:li>Gustav Buescher</rdf:li>
               <rdf:li>Lucy Meunier</rdf:li>
               <rdf:li>Pia Goeggelmann</rdf:li>
               <rdf:li>Francesca Fianchi</rdf:li>
               <rdf:li>Jérôme Dumortier</rdf:li>
               <rdf:li>Mar Riveiro Barciela</rdf:li>
               <rdf:li>Tom J. G. Gevers</rdf:li>
               <rdf:li>Benedetta Terziroli Beretta-Piccoli</rdf:li>
               <rdf:li>Maria-Carlota Londoño</rdf:li>
               <rdf:li>Sona Frankova</rdf:li>
               <rdf:li>Thomas Roesner</rdf:li>
               <rdf:li>Vincent Joerg</rdf:li>
               <rdf:li>Constantin Schmidt</rdf:li>
               <rdf:li>Fabian Glaser</rdf:li>
               <rdf:li>Jan P. Sutter</rdf:li>
               <rdf:li>Thorben W. Fründt</rdf:li>
               <rdf:li>Ansgar W. Lohse</rdf:li>
               <rdf:li>Samuel Huber</rdf:li>
               <rdf:li>Johann von Felden</rdf:li>
               <rdf:li>Marcial Sebode</rdf:li>
               <rdf:li>Kornelius Schulze</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default"/>
            </rdf:Alt>
         </dc:description>
         <dc:rights>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Copyright © 2024 Kocheise, Piseddu, Vonderlin, Tjwa, Buescher, Meunier, Goeggelmann, Fianchi, Dumortier, Barciela, Gevers, Beretta-Piccoli, Londoño, Frankova, Roesner, Joerg, Schmidt, Glaser, Sutter, Fründt, Lohse, Huber, von Felden, Sebode and Schulze. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</rdf:li>
            </rdf:Alt>
         </dc:rights>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:subject>
            <rdf:Bag>
               <rdf:li>autoimmune disease (AID)</rdf:li>
               <rdf:li>immune checkpoint inhibitors (ICI)</rdf:li>
               <rdf:li>autoimmune liver diseases (AILD)</rdf:li>
               <rdf:li>immune related adverse effects (irAEs)</rdf:li>
               <rdf:li>PD-1/PD-L1 immune checkpoint inhibitors</rdf:li>
               <rdf:li>autoimmune hepatitis (AIH)</rdf:li>
               <rdf:li>primary sclerosing cholangites (PSC)</rdf:li>
               <rdf:li>primary biliary cholangitis (PBC)</rdf:li>
            </rdf:Bag>
         </dc:subject>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Keywords>autoimmune disease (AID), immune checkpoint inhibitors (ICI), autoimmune liver diseases (AILD), immune related adverse effects (irAEs), PD-1/PD-L1 immune checkpoint inhibitors, autoimmune hepatitis (AIH), primary sclerosing cholangites (PSC), primary biliary cholangitis (PBC)</pdf:Keywords>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapRights="http://ns.adobe.com/xap/1.0/rights/">
         <xapRights:Marked>True</xapRights:Marked>
         <xapRights:WebStatement>https://www.frontiersin.org/legal/copyright-statement</xapRights:WebStatement>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:ModifyDate>2024-01-23T16:57:20+08:00</xap:ModifyDate>
         <xap:CreateDate>2024-01-23T16:57:20+08:00</xap:CreateDate>
         <xap:MetadataDate>2024-01-23T16:57:20+08:00</xap:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:69499052-26e2-43dc-9bbf-6e9551e66823</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:fabf1396-fe27-4dfc-9031-97bf44acf8ff</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 221, 685, 478, 706
      Annotation: 
       Subtype: Link
       Rect: 221, 660, 495, 681
      Annotation: 
       Subtype: Link
       Rect: 221, 635, 513, 656
      Annotation: 
       Subtype: Link
       Rect: 221, 610, 439, 631
      Annotation: 
       Subtype: Link
       Rect: 221, 585, 498, 606
      Annotation: 
       Subtype: Link
       Rect: 221, 560, 338, 581
      Annotation: 
       Subtype: Link
       Rect: 49, 33, 129, 40
      Annotation: 
       Subtype: Link
       Rect: 500, 33, 545, 40
      Annotation: 
       Subtype: Link
       Rect: 49, 690, 125, 705
      Annotation: 
       Subtype: Link
       Rect: 60, 587, 118, 594
      Annotation: 
       Subtype: Link
       Rect: 49, 379, 158, 386
      Annotation: 
       Subtype: Link
       Rect: 61, 293, 180, 300
      Annotation: 
       Subtype: Link
       Rect: 49, 284, 74, 291
      Annotation: 
       Subtype: Link
       Rect: 450, 802, 484, 809
      Annotation: 
       Subtype: Link
       Rect: 466, 793, 520, 800
      Annotation: 
       Subtype: Link
       Rect: 446, 783, 539, 790
      Annotation: 
       Subtype: Link
       Rect: 49, 789, 233, 806
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 64, 712, 531, 721
      Annotation: 
       Subtype: Link
       Rect: 64, 701, 162, 710
      Annotation: 
       Subtype: Link
       Rect: 249, 668, 344, 675
      Annotation: 
       Subtype: Link
       Rect: 224, 621, 250, 630
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 231, 596, 260, 605
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 449, 799, 545, 806
      Annotation: 
       Subtype: Link
       Rect: 49, 33, 129, 40
      Annotation: 
       Subtype: Link
       Rect: 500, 33, 545, 40
  Checksum: 57c01a1a
   Type: CRC32
  Checksum: f74f8ade03d6f160dd75c8ed4a2e7a94
   Type: MD5
  Checksum: 58ad1e103d70726931c5cca03006f7d127a19cdf
   Type: SHA-1
  Checksum: dfba1a76b03ee8d4ba185c894270dea9775b9f41e58458d4e9c04234daaad43c
   Type: SHA-256